Sickle Cells Show Potential to Attack Aggressive Cancer Tumors (DukeHealth.org)
Jan. 9, 2013
By harnessing the very qualities that make sickle cell disease a lethal blood disorder, a research team led by Duke Medicine and Jenomic, a private cancer research company in Carmel, Calif., has developed a way to deploy the misshapen red blood cells to fight cancer tumors.
Experts Identify Critical Genes Mutated in Stomach Cancer (DukeHealth.org)
Apr. 9, 2012
An international team of scientists, led by researchers from the Duke-NUS Graduate Medical School (Duke-NUS) in Singapore and National Cancer Centre of Singapore, has identified hundreds of novel genes that are mutated in stomach cancer, the second-most lethal cancer worldwide.
Discovery Could Reduce Chemotherapy's Side Effects (DukeHealth.org)
Mar. 11, 2012
A team of researchers at Duke University has determined the structure of a key molecule that can carry chemotherapy and anti-viral drugs into cells, which could help to create more effective drugs with fewer effects to healthy tissue.
Portion of New Duke Medicine Circle Opens Dec. 5 (http://construction.dukemedicine.org/)
Dec. 1, 2011
As part of preparations for the opening of the new Duke Cancer Center in February, a portion of the new Duke Medicine Circle will open to vehicular traffic on Dec. 5.
Costly Blood Clots More Common than Expected Among Cancer Patients (DukeHealth.org)
Sept. 19, 2011
An analysis of more than 30,000 cancer patients has shown that blood clots are a more common complication than doctors may realize, causing additional hospitalizations and driving up the cost of care, according to a study led by a Duke Cancer Institute researcher.
Duke Team Finds New Clues to How Cancer Spreads (DukeHealth.org)
June 27, 2011
Cancer cells circulating in the blood carry newly identified proteins that could be screened to improve prognostic tests and suggest targets for therapies, report scientists at the Duke Cancer Institute.